BACKGROUND: The relative effect of a transcutaneous peroneal nerve stimulator (tPNS) and an ankle foot orthosis (AFO) on spatiotemporal, kinematic, and kinetic parameters of hemiparetic gait has not been well described. OBJECTIVE: To compare the relative neuroprosthetic effect of a tPNS with the orthotic effect of an AFO using quantitative gait analysis (QGA). DESIGN: In all, 12 stroke survivors underwentQGA under 3 device conditions: (1) no device (ND), (2) AFO, and (3) tPNS. A series of repeated-measures analyses of variance (rmANOVAs) were performed with dorsiflexion status (presence or absence of volitional dorsiflexion) as a covariate to compare selected spatiotemporal, kinematic, and kinetic parameters for each device condition. Post hoc pairwise comparisons and/or subset analysis by dorsiflexion status were performed for significant effect. RESULTS:Stride length was improved with both the AFO (P = .035) and the tPNS (P = .029) relative to ND. Those with absent dorsiflexion had longer stride length with the tPNS relative to ND (P = .034) and a higher walking velocity with a tPNS relative to the AFO (P = .015). There was no device effect on dorsiflexion angle at initial contact; however, a significant Device × Dorsiflexion status interaction effect favored the AFO relative to ND (P = .025) in those with dorsiflexion present. CONCLUSION: This study suggests that level of motor impairment may influence the relative effects of the tPNS and AFO devices in chronic hemiparetic gait; however, the small sample size limits generalizability. Future studies are necessary to determine if motor impairment level should be considered in the clinical prescription of these devices.
RCT Entities:
BACKGROUND: The relative effect of a transcutaneous peroneal nerve stimulator (tPNS) and an ankle foot orthosis (AFO) on spatiotemporal, kinematic, and kinetic parameters of hemiparetic gait has not been well described. OBJECTIVE: To compare the relative neuroprosthetic effect of a tPNS with the orthotic effect of an AFO using quantitative gait analysis (QGA). DESIGN: In all, 12 stroke survivors underwent QGA under 3 device conditions: (1) no device (ND), (2) AFO, and (3) tPNS. A series of repeated-measures analyses of variance (rmANOVAs) were performed with dorsiflexion status (presence or absence of volitional dorsiflexion) as a covariate to compare selected spatiotemporal, kinematic, and kinetic parameters for each device condition. Post hoc pairwise comparisons and/or subset analysis by dorsiflexion status were performed for significant effect. RESULTS: Stride length was improved with both the AFO (P = .035) and the tPNS (P = .029) relative to ND. Those with absent dorsiflexion had longer stride length with the tPNS relative to ND (P = .034) and a higher walking velocity with a tPNS relative to the AFO (P = .015). There was no device effect on dorsiflexion angle at initial contact; however, a significant Device × Dorsiflexion status interaction effect favored the AFO relative to ND (P = .025) in those with dorsiflexion present. CONCLUSION: This study suggests that level of motor impairment may influence the relative effects of the tPNS and AFO devices in chronic hemiparetic gait; however, the small sample size limits generalizability. Future studies are necessary to determine if motor impairment level should be considered in the clinical prescription of these devices.
Authors: P N Taylor; J H Burridge; A L Dunkerley; D E Wood; J A Norton; C Singleton; I D Swain Journal: Arch Phys Med Rehabil Date: 1999-12 Impact factor: 3.966
Authors: T Bajd; M Stefancic; Z Matjacić; A Kralj; R Savrin; H Benko; T Karcnik; P Obreza Journal: Med Biol Eng Comput Date: 1997-03 Impact factor: 2.602
Authors: D Yao; E Jakubowitz; K Tecante; M Lahner; S Ettinger; L Claassen; C Plaass; C Stukenborg-Colsman; K Daniilidis Journal: Musculoskelet Surg Date: 2016-09-01
Authors: Nathaniel S Makowski; Rudi Kobetic; Lisa M Lombardo; Kevin M Foglyano; Gilles Pinault; Stephen M Selkirk; Ronald J Triolo Journal: Am J Phys Med Rehabil Date: 2016-12 Impact factor: 2.159
Authors: Luciana A Mendes; Illia Ndf Lima; Tulio Souza; George C do Nascimento; Vanessa R Resqueti; Guilherme Af Fregonezi Journal: Cochrane Database Syst Rev Date: 2020-01-14
Authors: Larry W Forrester; Anindo Roy; Charlene Hafer-Macko; Hermano I Krebs; Richard F Macko Journal: J Neuroeng Rehabil Date: 2016-06-02 Impact factor: 4.262